Better Dissemination and Implementation of Osteoarthritis Guidelines Needed

VBCR - April 2014, Volume 3, No 2 - Osteoarthritis
Alice Goodman

Contemporary guidelines for the management of osteoarthritis (OA) from different stakeholder organizations are generally consistent, according to a systematic review of the literature undertaken as an initiative of the Chronic Osteoarthritis Management Initiative Work Group (Nelson AE, et al. Semin Arthritis Rheum. 2013 Dec 4. Epub ahead of print).

But despite the existence of consistent guidelines across a number of medical societies and organizations, uptake and implementation of OA guidelines is suboptimal in the United States, Canada, and European countries, ranging from 22% to 57%.

“Many of these recommendations from stakeholder organizations are generally agreed upon and could be readily implemented in clinical practice for a variety of specialties providing care to OA patients,” lead author Amanda E. Nelson, MD, MSCR, University of North Carolina, Chapel Hill, told Value-Based Care in Rheumatology. “The vast majority of care for OA occurs in primary care settings and efforts aimed at dissemination and implementation of these guidelines should be directed toward these providers for maximum impact.”

Dissemination and implementation of guidelines is an important area that is now receiving much attention, according to the investigators. “No matter how important and clinically relevant research-based findings may be, it is only through dissemination and implementation that such guidelines and/or research will reach the clinicians and patients who may benefit,” she added. Implementation of evidence-based guidelines will be tied to reimbursement, and may be used to create quality indicators and assess patient satisfaction.

The present study was based on a MEDLINE literature search of articles published on OA guidelines from January 1, 2000, to April 1, 2013. Of 148 articles, 16 were eligible for inclusion and included in the final analysis. The articles comprised recommendations from the American College of Rheumatology, European League Against Rheumatism, American Association of Orthopedic Surgeons, Osteoarthritis Research Society International, as well as other societies.

Fifteen of the 16 articles included recommendations that were in general agreement for nonpharmacologic management of OA: education and self-management; exercise and weight loss; assistive devices; alternative and complementary approaches; and surgical interventions. Education guidelines included patient referral to self-management, provide education, joint protection strategies and individualized plans for patients with OA. Exercise—including low-impact aerobic exercise and consideration of range-of-motion exercises—and weight loss were recommended. Assistive devices such as walking aids were recommended as needed, but there was inconclusive evidence to support bracing or lateral heel wedges for knee OA and for splints for thumb-based OA.

Six guidelines included surgical interventions. Guidelines that did recommend joint replacement for appropriate patients with hip or knee OA, stated that arthroscopy with debridement was not recommended for the management of symptomatic knee OA.

Regarding pharmacologic management, the guidelines recommended acetaminophen/paracetamol as first-line therapy for symptomatic OA, and second-line treatment with topical agents and oral nonsteroidal anti-inflammatory drugs, with appropriate risk stratification and gastroprotective strategies. Tramadol (Ultram) was recommended for refractory symptoms, and possibly opioids or duloxetine. Intra-articular corticosteroids were recommended for knee and hip OA, but there was insufficient evidence to make a general recommendation regarding intra-articular hyaluronans.

Guidelines were conflicting regarding acupuncture, glucosamine/chondroitin, and intra-articular hyaluronans. “Dissemination and im­ple­­mentation efforts should focus not on controversial recommendations, but on those with universal agreement, such as those for education, exercise, and weight loss,” Dr Nelson and colleagues concluded.

Related Items
Working in Cold Environment Increases Risk for RA
Alice Goodman
VBCR - April 2018, Vol 7, No 1 published on April 17, 2018 in Rheumatoid Arthritis
Stem-Cell Transplant Improves Survival in Patients with Severe Scleroderma
Alice Goodman
VBCR - April 2018, Vol 7, No 1 published on April 17, 2018 in Scleroderma
Treatment with Methotrexate Alone Yields Similar Outcomes to Combination Therapy in Early RA
Alice Goodman
VBCR - April 2018, Vol 7, No 1 published on April 17, 2018 in Rheumatoid Arthritis
Adalimumab Biosimilar Shown to Be Safe and Effective in Patients with RA
Alice Goodman
VBCR - April 2018, Vol 7, No 1 published on April 17, 2018 in Rheumatoid Arthritis
Noises In and Around Joint Signal Future Knee Osteoarthritis
Anne Rowe
VBCR - April 2018, Vol 7, No 1 published on April 17, 2018 in Osteoarthritis
Retired UK Professional Football Players at Higher Risk for Knee OA Than Men in the General Population
Anne Rowe
VBCR - December 2017, Vol 6, No 5 published on December 19, 2017 in Osteoarthritis
New Algorithm Shows Promise in Predicting Progression of Knee Osteoarthritis
Rebecca Bailey
VBCR - October 2017, Vol 6, No 4 published on October 20, 2017 in Osteoarthritis
Opioid Use Before Knee Replacement Surgery Leads to Worse Pain Outcomes
Anne Rowe
VBCR - August 2017, Vol 6, No 3 published on August 23, 2017 in Osteoarthritis
High-Fiber Diet Associated with Reduced Risk for Painful Knee Osteoarthritis
Anne Rowe
VBCR - August 2017, Vol 6, No 3 published on August 23, 2017 in Osteoarthritis
Early Treatment of Rheumatoid Arthritis Improves Functional Outcomes at 20 Years
Alice Goodman
VBCR - June 2017, Vol 6, No 2 published on June 29, 2017 in Rheumatoid Arthritis
Last modified: May 21, 2015
  • Rheumatology Practice Management
  • Lynx CME
  • American Health & Drug Benefits
  • Value-Based Cancer Care
  • Value-Based Care in Myeloma
  • Value-Based Care in Neurology